Evaluation of Processes and Procedures for Care of the Opioid Recipient Patient in the Primary Care Setting by Sproat, Anne
Grand Valley State University
ScholarWorks@GVSU
Doctoral Projects Kirkhof College of Nursing
10-2018
Evaluation of Processes and Procedures for Care of
the Opioid Recipient Patient in the Primary Care
Setting
Anne Sproat
Grand Valley State University
Follow this and additional works at: https://scholarworks.gvsu.edu/kcon_doctoralprojects
Part of the Pharmacy Administration, Policy and Regulation Commons, Primary Care
Commons, and the Public Health Commons
This Project is brought to you for free and open access by the Kirkhof College of Nursing at ScholarWorks@GVSU. It has been accepted for inclusion in
Doctoral Projects by an authorized administrator of ScholarWorks@GVSU. For more information, please contact scholarworks@gvsu.edu.
Recommended Citation
Sproat, Anne, "Evaluation of Processes and Procedures for Care of the Opioid Recipient Patient in the Primary Care Setting" (2018).
Doctoral Projects. 70.
https://scholarworks.gvsu.edu/kcon_doctoralprojects/70
 
Running head: PROPOSAL DEFENSE   
  
  
 
 
1 
 
 
 
 
Evaluation of Processes and Procedures for Care of the Opioid Recipient Patient in the Primary 
Care Setting 
Anne Sproat  
                                       Kirkhof College of Nursing 
                                      Grand Valley State University 
Advisor: Amy Manderscheid, DNP, RN, CMSRN 
Advisory Team: Rebecca Davis, PhD, RN  
Site Mentor: Kimberly Lanning, DNP, MSN, FNP-BC, APRN 
October 5th, 2018 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PROPOSAL DEFENSE 
  
  
2 
Abstract 
Introduction: Chronic non-cancer pain is far reaching, affecting over 100 million Americans 
(Zgierska et al., 2018).  Opioids are commonly prescribed for chronic pain, with approximately 
20% of patients presenting to primary care offices with symptoms of pain or pain-related 
diagnoses (Dowell, Haegerich, & Chou, 2016). As a result, opioid prescribing rates are 
increasing at a faster rate for primary care practice compared with other specialties (Dowell et 
al., 2016). Within the United States population, it is estimated that three percent to four percent 
of the adult population are prescribed long-term opioids for the treatment of chronic non-cancer 
pain (Dowell et al., 2016). The use of opioid pain medication presents serious risks for patients 
receiving them, including overdose and opioid use disorder (Dowell et al., 2016). Long-term use 
of opioids for chronic pain is controversial and has been linked to dose-dependent harm, 
addiction, overdose, and death (Zgierska et al., 2018). Approximately 85% of those who misuse 
opioids obtain their main drug supply from opioid prescriptions (Zgierska et al., 2018). On the 
basis of Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria, it is 
estimated that 1.9 million Americans abuse or are dependent on prescription opioids (Dowell et 
al., 2016). Opioid-related deaths in the United States have increased dramatically, making this a 
national public health crisis (Zgierska et al., 2018).   
Objectives: The primary study objective is to assess whether evidence-based practice 
guidelines are being followed regarding the care being delivered to opioid recipient patients.  
Methods: This is a quality improvement project that will include a retrospective evaluation of 
quality measures for evidence-based care being delivered to opioid recipients. This project 
will occur at a primary care office that is part of a large mid-western healthcare system. 
Resources needed for this project include access to patient charts located at the primary care 
clinic, use of a laptop, space within the primary care clinic in which to work, and materials 
needed to produce a toolkit. Additional resources include collaboration with the site mentor 
and office manager, utilization of information technology (IT) personnel, and consultations 
with a statistician. To be included in the analysis, patients must meet the following inclusive 
criteria: age greater than or equal to 18 years old; active patient status (seen in the past three 
years); have a primary care provider within this office; do not have a diagnosis of malignant 
neoplasm or hospice status; and have at least one opioid prescription in the past 45 days that 
was not prescribed for acute pain. Medical records will be reviewed for adult patients at the 
primary care clinic who are currently prescribed opioids. Furthermore, medical records will be 
assessed for quality measures of evidence-based care. Evidence-based action plans and a 
toolkit will be presented and provided to the primary care office’s leaders, providers, and staff 
to continue to improve measures reflecting organizational goals and measurement targets.  
Results: Expected results include potential gaps of continual improvement in evidence-based 
care that is being provided to patients in the primary care setting. 
Conclusions: Expected conclusions include identified areas of quality measures for evidence-
based care. 
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Implications: Areas for practice change will be identified and strategies to improve quality 
measures of care will be implemented. Patients receiving an opioid prescription will receive 
evidence-based care leading to improvement in patient safety.  
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Evaluation of Processes and Procedures for Care of the Opioid Recipient Patient in the Primary 
Care Setting 
Assessment and treatment of chronic pain has been a challenge for healthcare providers 
and systems, as they have struggled to find a balance between effective treatment for chronic 
pain and its potential for harm (Dowell et al., 2016). Primary care clinicians report having 
concerns about prescribing opioids, feel they have had insufficient training in prescribing 
opioids, and find managing patients with chronic pain stressful (Dowell et al., 2016). Clinicians 
also report concerns about opioid medication misuse, addiction, and overdose (Dowell et al., 
2016). With increasing regulatory scrutiny at the federal and state levels surrounding opioid 
misuse, primary care clinicians are less willing to manage chronic non-cancer pain with long-
term opioid use (Jamison, Scanlan, Matthews, Jurcik, & Ross, 2016). Primary care clinicians 
also report difficulty in following opioid prescription guidelines, citing lack of time for opioid 
management practices (Becker, Merlin, Manhapra, & Edens, 2016). 
In 2016, the Centers for Disease Control and Prevention (CDC) released guidelines for 
prescribing opioids for chronic pain. The CDC conducted a clinical systematic review of the 
scientific evidence to identify effectiveness, benefits, and harms of long-term opioid therapy for 
chronic pain (Dowell et al., 2016). On the basis of this systematic review, the CDC developed 
the guideline for prescribing opioids to treat chronic pain. Clinicians should use urine drug 
testing before starting opioid therapy and at least annually to assess for prescribed medications, 
other controlled substances, and illicit drugs (Dowell et al., 2016). Whenever possible, clinicians 
should avoid prescribing opioids and benzodiazepines concurrently (Dowell et al., 2016). For 
patients who are found to have opioid use disorder, clinicians should offer or arrange evidence-
based treatment, usually with buprenorphine or methadone in combination with behavioral 
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therapies (Dowell et al., 2016). Additionally, patients with chronic pain should be assessed for 
depression, as this population is at a higher risk for developing depressive symptoms (Dowell et 
al., 2016). 
In Michigan, new laws have recently gone into effect and have been the catalyst for 
change within the healthcare organization where this quality improvement project will take 
place. Starting June 1st, 2018, all providers prescribing or dispensing a controlled substance were 
required to be registered with Michigan Automated Prescription System (MAPS) in order to 
remain compliant. In addition, starting June 1st, 2018, the prescriber must provide the following 
information to the patient before prescribing an opioid: 
• The danger of opioid addiction 
• How to properly dispose of an expired, unused, or unwanted controlled substance 
• That the delivery of a controlled substance is a felony under Michigan Law 
• If the patient is pregnant or is a female of reproductive age, the short and long-term 
effects of exposing a fetus to an opioid, including but not limited to neonatal abstinence 
syndrome 
After providing the information detailed above, the prescriber must obtain the signature of 
the patient or the patient’s representative on a start talking consent form. The signed form must 
be kept in the patient’s medical record. On July 1st, 2018, prescribers treating a patient for acute 
pain could not prescribe more than a seven day supply of an opioid within a seven day period. 
This information was disseminated to the primary care office via email communication with the 
office manager. The office manager passed these materials to providers and office staff during 
staff meetings.  
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Thus far, aside from the materials created by members of the organization’s opioid taskforce, 
no initiatives have been made to review or evaluate quality of care processes provided to opioid 
recipient patients. As evidence suggests, there are quality measures that should be part of how 
care is provided to patients being treated for chronic pain. In many health care settings, part of 
evaluating whether quality measures are being met involves implementation of quality 
improvement projects. The purpose of this written discussion is to describe a proposed evidence-
based quality improvement project that addresses standards of care for opioid recipient patients, 
in partial fulfillment of the Doctor of Nursing Practice degree. The assessment of the 
organization will be discussed, along with evidence that was gathered during a literature review.  
In addition, the project plan will be described in depth.  
Assessment of the Organization  
This Midwestern health system is a non-profit healthcare organization that is part of a 
larger over-arching multi-institutional Catholic health system, which is sponsored by Catholic 
Health Ministries (XXX, 2018). Becoming part of a larger entity occurred recently and has made 
this healthcare system part of the second largest Catholic healthcare system in the nation (XXX, 
2018). Within the West Michigan area, there are a total of 33 primary care offices that are part of 
the health system (XXX, 2018). To assess the organization, the Burke and Litwin Model of 
Organizational Performance and Change was utilized to explore the current needs within the 
organization and opportunities for change. Additionally, an assessment of the strengths, 
weaknesses, opportunities, and threats (SWOT) was completed to further analyze the identified 
problem. In combination, these two tools will serve as a platform for the completion of a doctoral 
nursing scholarly project.  
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Framework for Assessment 
The Burke and Litwin Model of Organizational Performance and Change was created to 
provide a guide for organizational diagnosis and manage organizational change (Burke & Litwin, 
1992).  The model is used to help assess organizational and environmental factors, and how these 
dimensions should be linked to achieve change in performance or practice (Burke & Litwin, 
1992). The model revolves around 12 organizational factors that interact together and affect one 
another (Appendix A). Burke and Litwin (1992) state that the two distinct variables within an 
organization are climate and culture. Climate can be defined in terms of organizational members’ 
perceptions, whereas culture can be defined in terms of values and beliefs (Burke & Litwin, 
1992). Within the model, there are variables that influence and are influenced by climate, and 
variables that are influenced by culture (Burke & Litwin, 1992). The variables that define 
organizational climate are transactional factors, and the variables that define culture are 
transformational factors (Burke & Litwin, 1992).  
 Transformational factors are considered the most influential forces of change and include 
the external environment, mission and strategy, leadership, organizational culture, and individual 
and organizational performance (Burke & Litwin, 1992). Burke and Litwin (1992) state that of 
those factors, external environment is arguably the most persuasive factor to drive change. 
Transformational factors require analysis at the organization’s macro level in order to identify 
which organizational dimensions need to be highlighted during the change process (Burke & 
Litwin, 1992).  
 Transactional factors are the structural pieces of the work climate and consist of 
exchanges among members of the organization (Burke & Litwin, 1992). The transactional 
factors explain reciprocity among people and groups for mutual gain (Burke & Litwin, 1992). 
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Transactional factors include management practices, structure, systems, work climate, tasks and 
individual skills, motivations, individual needs and values, and individual and organizational 
performance (Burke & Litwin, 1992).  
Ethics and Protection of Human Subjects 
An application for review and approval or exemption of this project will be submitted to 
the health care system’s Institutional Review Board and to Grand Valley State University. Aside 
from project planning, no project activities will commence until the review is completed and 
Board approval or exemption is granted. The purpose and scope of this project are limited to 
evidence-based practice improvement or quality improvement. No patient identifiable 
information will be collected. There are no physical, social, psychological, legal, or economic 
threats to patients in association with this project. The impact of the project will pose no risk to 
participants. All members of the project team have completed human subject protection training 
via the Collaborative Institute Training Initiative and their actions will be guided accordingly.  
Stakeholders 
Key stakeholders in standards of care for opioid recipient patients include the leaders of 
the healthcare organization, healthcare providers (physicians, nurse practitioners, physician 
assistants), nursing staff (registered nurse and licensed practical nurses), medical assistants, 
office leaders (office manager, office practice leader for physicians, office practice leader for 
nursing), pharmacists, and patients. Leaders of the healthcare organization are committed to 
providing the highest level of care to opioid recipient patients, as evidenced by the creation of 
the opioid taskforce. The healthcare providers who care for and prescribe to opioid recipient 
patients are committed to patient safety and providing evidence-based care, as evidenced by 
enacting new initiatives put for by the physicians from the opioid taskforce. This includes 
 
PROPOSAL DEFENSE 
  
  
12 
providing treatment forms, consent forms, and documenting that MAPS has been checked. 
Nurses and medical assistants work in tandem with the providers to care for the patient, assist 
with documentation, and assist with prescription re-fills. Pharmacists ultimately fill medications 
and deliver them to patients. Office leaders guide change management practices and are therefore 
key stakeholders. At the center of the stakeholder ring lies the patient, who represents the most 
important stakeholder. Patients who experience chronic pain and receive opioid prescriptions as 
treatment have the greatest vested interest in the care they receive from the healthcare 
organization.  
Strength, Weakness, Opportunity, Threat Analysis 
 The Strength, Weakness, Opportunity, Threat (SWOT) analysis is a tool used to look at 
the settings internal strengths and weaknesses, and external opportunities and threats that 
ultimately help or hinder an organization’s project for change (Moran et al., 2017). For this 
SWOT analysis, the focus is on the primary care office, yet the organization as a whole will be 
considered in the context of external opportunities and threats (Appendix B). The SWOT 
analysis was completed in tandem with the organizational assessment and provided structure for 
evaluating the primary care clinic and the organization as a whole.  
Strengths. Identified organizational strengths include affiliation with a larger health system. 
Being part of a larger health system allows access to many resources, both financially and in 
regard to professional talent and knowledge. The opioid taskforce is representative of pooling 
talent within a large organization. The opioid taskforce is a group of physicians that are 
passionate about the opioid epidemic and feel changes within the organization are needed. 
Having this taskforce in place represents a significant strength for the organization as a whole, 
and for projects that address opioids.  
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Staff members are committed to the organization’s mission and strategy and are therefore 
willing to change in order to improve care for patients. The environment is team-based and 
everyone strives to work cohesively. The majority of staff members at the primary care clinic are 
also flexible and open to new ideas. 
Other strengths include management and practice lead physician buy in for changes 
regarding the care of opioid recipient patients. The office manager and practice lead physician of 
this primary care clinic agree that in order to provide safe and effective care to opioid recipient 
patients, changes are needed to support each individual and team to achieve success, in which the 
care team has been given the resources in order to care for patients safely and effectively. 
Evidence-based practice initiatives represent changes in practice that increase patient safety and 
allow for providers to effectively care for their patients. The primary care office manager and 
practice lead physician concur that it is important for the providers within the office to increase 
evidence-based practice initiatives regarding care being delivered to opioid recipient patients, 
especially in the midst of a state-wide crisis. 
Weaknesses. Identified weaknesses related to providing safe and effective care to opioid 
recipient patients include practice inconsistencies. There is one staff member in the office that 
has already begun creating a new work flow process regarding practice changes required by law, 
instead of waiting for official instruction from the opioid taskforce. It may be difficult for some 
staff to accept new changes and to become consistent in both work flow and documentation. 
Some providers and nursing staff may feel negatively towards change because its seen as 
increasing their workload or making it more difficult to care for their patients. Some staff 
members have reported that they believe these changes will make their work more stressful, 
because patients who receive opioids are in distress over changes occurring with their care and 
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express these concerns to staff. While the majority of the staff are receptive to change, even a 
few staff members with negative attitudes represent a weakness within the primary care office. 
Additionally, there are no systems in place to assess whether providers and staff are practicing 
based on recommendations from the opioid taskforce, or whether they are practicing evidence-
based care. 
Opportunities. Opportunities identified for the primary care office include the attention the 
opioid epidemic is receiving at the national and state levels. Nationally, President Trump has 
declared the opioid crisis a national public health emergency under federal law and directed all 
executive agencies to use all available resources to fight the opioid crisis (The White House, 
United States Government, 2017). At the state level, politicians are equally concerned and have 
passed new laws to help reduce prescription opioid abuse and decrease the number of deaths 
related to opioid overdose (Michigan State Medical Society, 2018). At the organizational health 
systems level, there is a group of physicians whom are part of the opioid taskforce that have been 
appointed with guiding the outpatient settings through this practice change. The members of the 
taskforce intend to provide the primary care offices with tools, resources, and policies related to 
opioid prescription and the care of opioid recipient patients. 
Threats. Threats to proposed practice change include negative attitudes held by opioid recipient 
patients regarding satisfaction with their care. Many patients have voiced concern that they are 
fearful they will no longer be given opioids for the treatment of chronic pain. Some patients have 
called the office in anger and frustration in regard to recent changes in Michigan law. This in 
turn causes staff to experience increased stress levels and feelings of resistance to change in 
practice.  
In addition, patients will be required to complete additional forms and consents and will 
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be subject to random urine drug screens. Prescriptions may change or decrease depending on 
how they are currently prescribed. All of these changes may result in dissatisfaction among this 
patient population. 
Clinical Practice Question 
The identified clinical problem is related to opioid prescription and the standards of care 
for opioid recipient patients. In order to solve this problem, a quality improvement intervention 
must address the following clinical question:  Are providers at the XXX primary care setting 
utilizing evidence-based practice when caring for opioid recipient patients? 
Review of the Literature 
Method 
A comprehensive electronic search was conducted in PubMed, CINAHL, and Web of 
Science Core Collection and was limited to reviews in the English language during the period of 
2014 to 2018. Keywords were drug monitoring, guideline, opioid, and primary care. Similar 
search terms were used by utilizing Boolean operators (OR, AND) which effectively broadened 
the search to include all relevant articles. The search yielded 332 articles. A total of nine 
duplicates were found. Each review was screened using inclusion and exclusion criteria 
(Appendix C). Review of titles and abstracts resulted in removal of 257 articles that did not meet 
the inclusion criteria. Additionally, a total of 69 articles were excluded after further examination 
of content, as they did not meet inclusion criteria. Many of the articles were reporting on the 
same guidelines that were released through the United States Centers for Disease Control and 
Prevention and were therefore excluded.  The remaining six articles were included in this review. 
The types of articles and study designs include case studies, pre and post intervention patient 
cohorts, and a multi-pronged quality improvement project. Higher level evidence articles include 
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critically appraised topics with evidence synthesis and guidelines, systematic review, and 
prospective longitudinal controlled trial. While randomized controlled trials and evidence 
reflecting the highest levels of research were desired, it was acknowledged that proper opioid 
management may be a relatively new topic. Considering the 2017 announcement of the opioid 
epidemic, applicable research may be currently occurring, and has not been published for review 
and translation into practice.  
PRISMA 
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) is 
an evidence-based set of items for reporting in systematic reviews and meta-analyses (Moher, 
Liberati, Tetzlaff, & Altman, 2009). PRISMA focuses on the reporting of reviews evaluating 
randomized control trials and is particularly useful when evaluating interventions (Moher et al., 
2009). The process utilizes a flow diagram that depicts the flow of information through the 
different phases of the systematic review (Moher et al., 2009). The flow diagram maps out the 
number of articles identified, which were included and excluded, and the reasons why certain 
articles were excluded (Moher et al., 2009). The PRISMA flow diagram was utilized during the 
literature review process for this project and provides meaningful understanding regarding how 
the literature review was completed (Appendix C).  
Summary of Results 
Upon review of the six articles selected to be a part of the literature review, a table was 
created to organize the information (Appendix D). Findings of this literature review highlight the 
guidelines for opioid prescription, as reported by the CDC (Dowell et al., 2016). To gain better 
understanding of how the guidelines operate and are utilized in the primary care setting, evidence 
was reviewed, and it was determined that interventions exist that make guideline implementation 
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more successful. Quality improvement projects have the propensity to enhance uptake of opioid 
policies in primary care (Zgierska et al., 2018). In addition to guideline implementation, the 
primary care provider must also become proficient in the management of patients with issues 
related to opioid safety, efficacy, and misuse (Becker et al., 2016). Primary care practitioners 
must also be equipped with strategies for preventing and managing aberrant opioid-related 
behaviors (Argoff et al., 2014). Evidence supports that there are interventions that assist 
providers with identifying patients at risk for misuse, increase provider confidence with opioid 
prescription, and increase positive communication with pain specialists (Jamison et al., 2016). 
Evidence to be used for Project 
The results of the literature review suggest that current standards of care regarding opioid 
prescription involve numerous activities that must be carried out by the prescriber. These 
activities are aimed at patient safety. The following paragraphs will discuss these actions in 
detail. 
First and foremost, the patient should have a documented diagnosis of chronic pain, 
including the source of the pain and any details pertaining to the diagnosis (Dowell et al., 2016). 
This activity represents best practice and allows for improved intra-professional communication 
(Dowell et al., 2016). According to the CDC, it is also important that the prescriber documents 
morphine milligram equivalents per day in order to gain understanding of how much opioid the 
patient is ingesting per day (Dowell et al., 2016). Higher amounts of morphine milligram 
equivalents places the patient at a higher risk for overdose and death, and it is something the 
provider needs to take into consideration (Dowell et al., 2016). Calculating the morphine 
milligram equivalent essentially acts as a forewarning to the provider, allowing them to mitigate 
risk by prescribing naloxone and providing education to the patient and their family (Dowell et 
 
PROPOSAL DEFENSE 
  
  
18 
al., 2016). Acknowledging concurrent benzodiazepine use is also evidence-based practice, 
because it places the patient at risk for respiratory depression and accidental overdose (Dowell et 
al., 2016). In addition, in alignment with evidence-based care, providers should be screening 
patients with chronic pain for depression since this population is at a high risk for developing 
concurrent depression (Zgierska et al., 2018). This can be achieved by using either the patient 
health questionnaire-2 (PHQ-2) or patient health questionnaire-9 (PHQ-9). 
In order to identify and remedy aberrant behaviors related to opioid abuse, there are 
several evidence-based practice activities that prescribers should utilize. Providers should use 
urine drug testing before starting opioid therapy and at least annually to assess for prescribed 
medications, other controlled substances, and illicit drugs (Dowell et al., 2016). 
Limitations of the literature review include the lack of high-level evidence, such as 
systematic reviews or meta-analyses. Because the opioid epidemic has only recently been 
declared a national crisis, high-level evidence in this arena simply has not been published. 
Therefore, recommendations implemented in practice are derived from a report published by the 
CDC (Dowell et al., 2016). It is clear that more research is needed to ensure safe practices 
regarding opioid prescribing and management practices.  
Phenomenon Conceptual Model 
 Conceptual models serve as guides in understanding a phenomenon and also guide 
change initiatives within an organization. The Donabedian Model is a conceptual model that 
evaluates main dimensions of health care quality (Donabedian, 1988). These three main 
components include structure, process, and outcomes, and each component has a direct influence 
on the next (Appendix E). Structure has an effect on process measures, which in turn affect 
outcomes (Donabedian, 1988).  
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Structure 
 According to the Donabedian Model, structure refers to the characteristics of personnel 
who provide care to patients and the setting where care is being delivered (Donabedian, 1988). 
Structure measures reflect the attributes of the provider and organizational characteristics 
(Donabedian, 1988). In regard to this project, structure measures include use of electronic 
medical records and the strong support from physicians and staff within the healthcare 
organization. The physicians working within the opioid taskforce have initiated practice changes 
that reflect new Michigan state laws for opioid prescription. These initiatives have led to changes 
in the attitudes of the personnel providing care to patients, and all staff members are now aware 
of the seriousness of the opioid epidemic. Organizational leaders are currently putting other 
structures into place that embed certain aspects of care into the electronic health record, 
including the signed consent form, treatment agreement form, and verification of checking 
MAPS. However, the process for these structures being placed in the electronic health record 
have been put on hold because the organization will be changing its electronic record system 
within the next year.  
Process 
 Process refers to all of the activities taking place while care is being delivered to the 
patients (Donabedian, 1988). Process measures reflect the way a healthcare system processes 
work to deliver desired outcomes (Donabedian, 1988). Examples include the length of time a 
patient waits for their appointment, if patients are receiving certain standards of care, and if staff 
are recording incidents that occur during a patient visit (Haj, Lamrini, & Rais, 2013). For this 
project, process measures include whether patients are receiving evidence-based standards of 
care, and whether these actions are integrated within care processes in tandem with proper 
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documentation. This includes a documented urine drug screen, documented diagnosis of chronic 
pain and the source of pain, documented concurrent benzodiazepine prescription, documented 
depression screening, and documented morphine milligram equivalent.  
Outcomes 
 Quality of care can be assessed in terms of outcome measures which include health status 
indicators, as well as cost of care and patient satisfaction (Donabedian, 1988). Classic examples 
of outcome measures include reduced mortality, reduced length of stay, reduced infection rates, 
and improved patient experience (Haj et al., 2013). For this quality improvement project, 
outcome measures include percentages of eligible adult patients with completed urine drug 
screening, documented depression screening, documented concurrent benzodiazepine 
prescription, documented diagnosis of chronic pain with source, and documented morphine 
milligram equivalent.  
Project Plan 
 This Doctor of Nursing Practice (DNP) project will be focused on assessing evidence-
based care that is currently being delivered to adult opioid recipient patients.  The quality 
measures that have previously been discussed will be audited through the access of patient 
charts. The results of the audit will be presented as percentages, depicting what percentage of 
patients are receiving evidence-based care for each of the quality measures. The results of the 
audit will be used to meet project goals, including development of a toolkit for continued 
improvement and sustainability of quality measures, and may be used to guide future initiatives.  
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Purpose of Project and Objectives 
The purpose of this Doctor of Nursing Practice project is to implement a quality 
improvement program for standards of care regarding adult opioid recipient patients in tandem 
with designing an evidence-based toolkit for improvement and sustainment. This quality 
improvement project will be implemented using the Plan-Do-Study-Act model and an applicable 
toolkit.  
Assessing the current state of evidence-based practice and improving upon the care being 
delivered to opioid recipient patients will be attempted by the DNP student through the following 
objectives: 
• Complete a gap analysis for opioid prescription evidence-based practice in the 
primary care setting for adult patients receiving opioids by November 30th, 2018 
• Communicate findings with leaders, providers, and office staff by March 31st, 
2019 
• Collaborate with leaders, providers, and office staff to design improvement and/or 
sustainment strategies by January 2019 
• Design a toolkit with evidence-based improvement and sustainment 
recommendations by January 2019 
Design for the Evidence-based Initiative 
This is a quality improvement project that will include a retrospective evaluation of 
quality measures for evidence-based care being delivered to opioid recipient patients. After 
determination and approval from both the health care organization and Grand Valley State 
University institutional review boards, the Doctor of Nursing Practice student will perform chart 
audits of adult patients receiving opioid prescriptions from the primary care clinic. This 
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collection of data will begin November 2018 and will continue until April 2019. The data will be 
analyzed using descriptive statistics, and results will be presented to office leaders, providers, 
and staff for a collaborative discussion. Strategies for improvement and sustainment will be 
developed. In addition, a toolkit will be designed that addresses the gaps previously identified in 
the care being delivered to opioid recipient patients. The toolkit will also contain a checklist for 
prescribing opioids for chronic pain, treatment alternatives for chronic pain, strategies for 
minimizing opioid prescription abuse, and responding to aberrant drug-related behaviors. 
Setting  
The project will be conducted in a primary care office that is affiliated with a larger 
health system. The health system is a non-profit healthcare organization that is part of a larger 
multi-institutional Catholic health system (XXX, 2018). Within the West Michigan area, there 
are a total of 33 primary care offices that are part of the healthcare system (XXX, 2018). 
Services are provided to patients of all ages, with a strong focus on wellness and disease 
prevention. The providers assess and treat patients for acute illness and chronic disease 
management as well. The population they serve is not only diverse in age, but also in ethnicity 
and culture. The Doctor of Nursing Practice student has secured administrative approvals to 
conduct this quality improvement project from the health care organization (Appendix G) and 
Grand Valley State University (Appendix H).  
Participants   
To be included in the analysis, patients must meet the following criteria: age 
greater than or equal to 18 years old; active patient status (seen in the past three 
years); have a primary care provider within this office; do not have a diagnosis of 
malignant neoplasm or hospice status; and have at least one opioid prescription in 
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the past 45 days that was not given for acute pain. Patients will be excluded if they 
are younger than 18 years of age, have not been seen in the past three years, have a 
diagnosis of malignant neoplasm or are currently hospice status, or have not been 
given an opioid prescription in the last 45 days.  
Model Guiding Implementation 
 The Plan-Do-Study-Act (PDSA) model is a four-stage problem-solving model that is 
used to improve a process and carry out changes within an organization (Appendix F). The 
PDSA model is typically used for small to medium scaled quality improvement projects 
(Institute for Healthcare Improvement, 2018). Improving quality means making healthcare safer, 
more efficient, patient centered, effective, and equitable (Donnelly & Kirk, 2015). 
 Plan. The first step of the planning stage is to assemble a team that has knowledge of the 
problem (Institute for Healthcare Improvement, 2018). Roles and responsibilities need to be 
identified, timelines must be set, and a meeting schedule must be established (Institute for 
Healthcare Improvement, 2018). Next, an aim statement should be made, which states what is 
trying to be accomplished and what changes can be made to improve the situation (Institute for 
Healthcare Improvement, 2018). Current process needs to be examined by completing a 
strengths, weakness, opportunities, and threats (SWOT) analysis (Institute for Healthcare 
Improvement, 2018). After the SWOT analysis is completed, a problem statement must be 
written to clearly summarize the problem (Institute for Healthcare Improvement, 2018). Lastly, 
an action plan needs to be developed that includes necessary resources and a timeline (Institute 
for Healthcare Improvement, 2018). 
 Do. The second step is to implement the action plan that was developed in step one. Data 
collection occurs during this step from a particular point in time and is measured over a period of 
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time in order to record patterns in the data (Donnelly & Kirk, 2015). The investigator should also 
document problems, unexpected findings, and general observations (Institute for Healthcare 
Improvement, 2018). 
 Study. The third step of the process is to use the aim statement from step one and the 
data gathered in step two in order to determine results and trends in the data (Institute for 
Healthcare Improvement, 2018). This involves studying and analyzing the data and the process 
itself (Donnelly & Kirk, 2015). To facilitate seeing trends in data, descriptive statistics can be 
used to present the data in a meaningful way. Information can be displayed in graphs and charts 
for ease of use.  
 Act. The fourth step of the process is to determine whether the plan resulted in success, 
or whether the process needs to be re-examined (Institute for Healthcare Improvement, 2018). 
Accomplishments from the project should be communicated to appropriate personnel and steps 
to preserve gains and sustain accomplishments should be taken (Institute for Healthcare 
Improvement, 2018). Lastly, the project should be documented and what was learned from the 
process must be clearly expressed (Donnelly & Kirk, 2015).   
 According to current evidence, standards of care for opioid recipient patients were 
identified and recommendations were published for primary care providers as a guide (Dowell et 
al., 2016). Current literature also provides evidence that providing health care providers with 
educational interventions, such as toolkits, can positively impact the care they provide to their 
patients (Zgierska et al., 2018). In order to complete this quality improvement project, the Doctor 
of Nursing Practice student will use the PDSA model as a guide for implementation, which will 
be discussed in the following sections. 
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Implementation Steps and Strategies 
 This quality improvement project will be implemented at a primary care clinic. Project 
procedures will occur tentatively between November 5, 2018-April 1, 2019. The project steps 
are as follows: 
1. The Doctor of Nursing Practice student will perform chart audits at the primary care 
clinic on a monthly basis between November 2018 until April 2019, and data will be 
collected for evidence-based quality measures including the following: 
a. Documented urine drug screening (at least annually) 
b. Documented diagnosis of chronic pain and source of pain 
c. Documented concurrent benzodiazepine prescription 
d. Documented depression screening (PHQ 2 or PHQ 9) 
e. Documented morphine milligram equivalent (MME) 
2. The Doctor of Nursing Practice student will collaborate with information technology 
personnel in order to obtain reports that address the evidence-based quality measures 
outlined in step one. This will be completed by January 31, 2019. 
3. The Doctor of Nursing Practice student will assess the use of evidence-based practice 
guidelines by analyzing the gathered data using descriptive statistics. This will include 
a consultation with a statistician. Graphs and pie charts will be utilized in order to 
present the information in a meaningful way. This will be completed by March 31, 
2019. 
4. The Doctor of Nursing Practice student will communicate findings with leaders, 
providers, and office staff by April 30, 2019. Results of chart reviews, including 
statistics and outcomes reflecting quality improvement initiatives will be presented to 
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providers at the primary care office that shows collective results of the following 
quality measures: 
a. Percent of eligible adult patients with urine drug screening completed 
b. Percent of eligible adult patients with documented screening using PHQ 2 or 
PHQ9 depression screening tool 
c. Percent of eligible adult patients with documented concurrent benzodiazepine 
prescription  
d. Percent of eligible adult patients with documented diagnosis of chronic pain 
and source of pain 
e. Percent of eligible adult patients with documented morphine milligram 
equivalent (MME) 
5. The Doctor of Nursing Practice student will collaborate with leaders, providers and 
office staff to design improvement strategies that reflect organizational goals and 
sustainment strategies. This will be completed by February 28, 2019.  
6. The Doctor of Nursing Practice student will develop a toolkit with evidence-based 
improvement and sustainment recommendations. The content of the toolkit will be 
based upon results obtained during data collection and data analysis. This will be 
completed by March 31, 2019. 
7. The Doctor of Nursing Practice student will share recommendations for improvement 
of quality measures with leaders, providers and office staff by April 30, 2019. 
8. The Doctor of Nursing Practice student will deliver an evidence-based toolkit to 
organizational leaders, providers and office staff by April 30, 2019. The toolkit content 
will entail the following at minimum: 
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a. Checklist for prescribing opioids for chronic pain 
b. Treatment alternatives for chronic pain 
c. Strategies for minimizing opioid prescription abuse and responding to aberrant 
drug-related behaviors 
9. The Doctor of Nursing Practice student will ensure a sustainment plan is in place that 
includes the following: 
a. The identification of a staff member within the organization to monitor quality 
indicators after the student has finished the project by April 30, 2019. 
b. The organization will be presented with a toolkit for future use in practice, 
which will act as guide for everyday practice by April 30, 2019. 
Measures 
 The first indicator to be assessed is whether the clinical question was able to be answered 
through the completion of a gap analysis for opioid prescription in the primary care setting. Data 
obtained from chart review and reports obtained through the assistance of information 
technology personnel will be analyzed by the Doctor of Nursing Practice student with the 
assistance of a statistician. The data will be presented through descriptive statistics and will be 
utilized in determining the answer to the previously stated clinical question.  
The next indicator to be assessed includes whether findings were able to be 
communicated with leaders, providers and office staff. This will be achieved during a monthly 
staff meeting in March 2019. This will require collaboration with, along with approval from the 
office manager.  
Lastly, indicators include whether an evidence-based toolkit was designed through 
collaboration with leaders, providers and office staff that includes improvement and sustainment 
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recommendations. The Doctor of Nursing Practice student will develop the toolkit based on 
needs identified during data analysis. The toolkit will be tailored to address measures that were 
found to be less than satisfactory.  
Data Collection Procedures 
The data collection will be conducted by the Doctor of Nursing Practice student. The data 
will be collected from two separate timeframes, which will be June 1st, 2018, to September 30th, 
2018, and October 1st, 2018, to January 31st, 2019. All data collection will take place onsite at the 
primary care office and will occur between November 5th, 2018 and April 1st, 2019. The data will 
be collected from electronic health records of patients that fit the specified criteria. Again, this 
will include documentation of a urine drug screen, documentation of depression screening, 
documentation of morphine milligram equivalents, documentation of chronic pain diagnosis with 
source of pain, and documented concurrent benzodiazepine use. At this time, the sample size is 
not known. For this quality improvement project, an instrument will not be used for data 
collection, such as a questionnaire. Instead, the data will be collected during chart audits. The 
data collected from the patient charts by the Doctor of Nursing Practice student will be entered 
into a spreadsheet that can later be used for analysis by a consulting statistician.  
Data Management   
 The Doctor of Nursing Practice student will be responsible for data management. The 
data will be generated through chart audits conducted by the Doctor of Nursing Practice 
student and entered into a spread sheet. The student will also consult with information 
technology personnel to obtain aggregate data. At this point, it has not been determined which 
measurements are capable of being pulled through reports generated by information 
technology personnel within the organization. There will be no identifiable data. Only project 
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team members and the consulting statistician will have access to the data and use it for 
completion of this project. All study records and data will be kept and accessible for a 
minimum of seven years, as required by the healthcare organization. 
Analysis  
Summary/descriptive statistics will be used to summarize the data in a meaningful way, 
allowing for simpler interpretation of the data. Frequency and percentage statistics will be 
utilized to present the data.  The analysis will be completed by the Doctor of Nursing Practice 
student and a Grand Valley State University statistician. The data will be displayed using graphs, 
tables, and pie charts. Using the graphs, tables, and pie charts will allow the Doctor of Nursing 
Practice student to identify which measures will require the greatest amount of educational 
material to be presented in the toolkit. For example, if the majority of patients do not have a 
documented urine drug screen, there will be an educational element within the toolkit that 
addresses strategies to improve that quality measure.  
Resources & Budget 
 The financial operating plan for this quality improvement project includes an 
evaluation of revenue and expenses (Appendix I). Expenses for this project include 
time and resources required of the Doctor of Nursing Practice student to gather data 
from patient charts, develop educational and toolkit materials, and implement 
education to the providers, leaders, and staff within the primary care office. The 
largest cost for this project is the time that the Doctor of Nursing Practice student is 
providing to the organization. This donation of time by the Doctor of Nursing 
Practice student will be made in an in-kind donation. The project site mentor and 
primary care office manager will also be providing an in-kind donation of time to the 
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organization by assisting the student with the project. Other costs of the project 
include consultations with a statistician and information technology staff. Additional 
costs also include laptop, the cost of occupying office space, and the cost of printed 
education and toolkit material. 
The budget table displays data in both the expenses and revenue columns that 
are similar. This was done intentionally to show that the time and resources needed 
to support this quality improvement project were donated and can be considered 
revenue. However, if the staff were removed from their regular practices to 
participate in a meeting specific to the project, there is an expense for their time. The 
presentation of project findings and subsequent educational session will be 
completed during a staff meeting, therefore no additional costs for reimbursing staff 
will be incurred. However, it is important to consider the cost for their time, as there 
are six physicians, two nurse practitioners, and one physician assistant that will be 
present at the provider meeting. The average hourly wage for a primary care 
physician is $100 (Salary.com, 2018a). The average hourly wage for primary care 
nurse practitioners is $48 (Salary.com, 2018b). The site mentor for the project is a 
nurse practitioner, and it is estimated that she will spend an additional 30 hours 
working on the project in collaboration with the Doctor of Nursing Practice student. 
The average hourly wage for a primary care physician assistant is also $48 
(Salary.com, 2018c). The office manager, and two staff lead registered nurses will 
also be present at the meeting. The average hourly wage for the office manager is 
$30 (Payscale.com) and her estimated time spent contributing to the project is 15 
hours. The average hourly wage for registered nurses is $26 (Payscale.com, 2018b). 
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Consultations for the project will include a statistician and information 
technology personnel. It is estimated that the statistician will spend 6 hours 
analyzing data and producing meaningful descriptive statistics, with an average 
hourly wage of $50 (Salary.com, 2018d). It is estimated that information technology 
personnel will spend 5 hours complying reports for the project, with an average 
hourly wage of $32 (Salary.com, 2018e).  
To mitigate costs incurred, it is important to consider the costs associated 
with risks of not implementing this project. This includes the value placed on human 
life and patient safety. Standards of care regarding opioid prescription as described 
in the literature strive to save lives by helping providers practice in a way that 
decreases risk of opioid overdose, whether it be intentional or accidental.  
Timeline 
Project planning began spring of 2018 with the completion of a project 
prospectus. During summer of 2018, an organizational assessment and literature 
review were completed. During fall of 2018, project planning continued, and 
documents were submitted to the healthcare organization’s institutional review 
board and Grand Valley State University’s institutional review board. The student 
will make a formal project presentation November 5th, 2018 that outlines the project 
for project members and advisors. The project work will take place between 
November 5th, 2018 and April 1, 2019.  Data collection will take place between 
November 5th, 2018 and January 31st, 2018. After data collection is completed in 
January 2018, the student will compile the results and present them to the healthcare 
organization and Grand Valley State University team members in a final project 
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defense.  
Sustainability Plan 
 Sustainability is a vital piece to include when planning and implementing a 
quality improvement project.  If a sustainability plan is not part of the project, the 
staff of the organization may find themselves repeatedly solving the same problems. 
In an effort to promote sustainability, the sustainability plan will address two 
categories which include staff and process. The sustainability plan for this project 
includes the identification of a staff member within the organization to monitor 
quality indicators. It is important that this individual is someone that is invested in 
the organization and is passionate about improving quality of care and patient safety. 
This could potentially be the practice lead physician or the office manager. In order 
to promote sustainability at a process level, the organization will be presented with a 
toolkit for future use in practice. By providing a toolkit, the providers and staff 
members will have access to resources that positively impact the care they provide. 
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Appendix A 
The Burke-Litwin Model 
 
A Model of Organizational Performance and Change.  Burke, W. W., & Litwin, G. H. (1992). A 
causal model of organizational performance and change. Journal of Management, 18(3), 
523-545.   
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Appendix B 
SWOT Analysis  
Strengths Weaknesses 
  
• Support of larger health care system 
• Positive culture within setting, 
motivated to keep patients safe 
• Management and practice lead buy in 
• Strong working relationships 
• Strong leadership 
• Strong emphasis on evidence-based 
practices 
• Current initiatives that address care 
processes regarding opioid 
prescription  
• Negative attitudes within the primary 
care office among some individuals 
• Practices vary within the 
organization’s primary care offices 
• Currently no system in place to 
evaluate current practices regarding 
care of opioid recipient patients 
Opportunities Threats 
• US government has declared the 
opioid crisis a national public 
emergency 
• New state laws regarding opioids to 
combat the opioid epidemic 
• Organizational opioid taskforce 
• Negative attitudes and beliefs held by 
some opioid recipient patients 
• Negative attitudes and beliefs held by 
some staff members 
• Electronic health system changes 
occurring in the near future prohibit 
growth within current electronic 
system 
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Appendix C 
Flow Diagram 
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Appendix D 
Table of Evidence 
Author (Year), Title, 
Purpose 
Design (N) Intervention/ 
Methods 
Results Conclusion 
Argoff, C. E., Kahan, M., & 
Sellers, E. M. (2014). 
Preventing and managing 
aberrant drug-related behavior 
in primary care: systematic 
review of outcomes evidence. 
Purpose: To review evaluated 
data supporting basic strategies 
for addressing aberrant opioid-
related behaviors. 
Systematic 
Review 
PubMed was 
searched using 9 
general headings 
related to 
minimizing 
opioid abuse risk 
and addressing 
aberrant drug-
related behavior. 
Nine distinct strategies for 
minimizing abuse and responding 
to aberrant drug-related behaviors 
were identified and discussed. 
Weak to 
moderate evidence suppor
ts the value of thorough 
patient assessment, risk-
screening tools, 
controlled-substance 
agreements, careful dose 
titration, opioid dose 
ceilings, compliance 
monitoring, and 
adherence to practice 
guidelines. Moderate to 
strong evidence suggests 
that prescribing tamper-
resistant opioids may help 
prevent misuse but may 
also have the unintended 
consequence of 
prompting a migration of 
users to other marketed 
opioids, heroin, or other 
substances. 
Becker, W. C., Merlin, J. S., 
Manhapra, A., & Edens, E. L. 
(2016). Management of patients 
with issues related to opioid 
safety, efficacy and/or misuse: a 
Case studies 
(Series of 3) 
The authors 
present three 
cases referred to 
their primary 
care clinic that 
highlight 
With respect to assessment, the 
cases represent making the 
diagnosis of opioid use disorder, 
allowing the patient space, 
identification of co-occurring 
hazardous alcohol use, and 
The three cases represent 
common challenges at the 
intersection between 
chronic pain and opioid 
safety, efficacy and 
misuse. 
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case series from an integrated, 
interdisciplinary clinic. 
Purpose: To improve the 
quality of care of patients with 
co-occurring chronic pain and 
issues related to opioid safety, 
efficacy and/or misuse. 
complex clinical 
scenarios. 
recognizing barriers to multimodal 
pain care. With respect to 
treatment, the cases represent 
changes in treatment with which 
the patient may not agree, 
effectiveness of 
buprenorphine/naloxone for 
treatments of chronic pain and 
making continued opioid therapy 
contingent on engagement with 
substance abuse treatment. 
Chen, J. H., Hom, J., Richamn, 
I., Asch, S. M., Podchiyska, T., 
& Johansen, N. A. (2016). 
 
Effect of opioid prescribing 
guidelines in primary care. 
Purpose: Assemble 
comprehensive guidelines for 
chronic opioid prescribing, 
including monitoring and 
referral recommendations. 
Disseminate guidelines in 
primary care.  
 
Pre and post 
intervention 
patient 
cohorts 
(N=119) 
Guidelines were 
disseminated 
through 
presentation at 
mandatory 
meetings and e-
mail distribution. 
Pre and post 
intervention 
evaluation 
periods to 
identify changes 
in patient and 
provider 
behaviors. 
After disseminating guidelines, the 
percentage of noncancer clinic 
patients receiving any opioid Rxs 
dropped from 3.9% to 3.4% 
(P = 0.02). The percentage of 
noncancer patients receiving 
chronic opioid Rxs decreased from 
2.0% to 1.6% (P = 0.03). The rate 
of urine drug screening increased 
from 9.2% to 17.3% (P = 0.005) 
amongst noncancer chronic opioid 
patients. 
 
An educational 
intervention for opioid 
prescribing in a general 
primary care setting is 
feasible and may be 
expected to modestly 
reduce overall opioid Rx 
rates and increase 
provider use of systematic 
monitoring methods. 
Dowell, D., Haegerich, T. M, & 
Chou, R. (2016). 
CDC Guideline for Prescribing 
Opioids for Chronic Pain- 
United States, 2016. Purpose: 
To report guidelines from CDC 
that addresses 1) when to 
Critically 
appraised 
topic- 
Evidence 
synthesis 
and 
guidelines 
CDC developed 
the guideline 
using the 
Grading of 
Recommendatio
ns Assessment, 
Development, 
Guidelines for prescribing opioids 
for chronic pain were created, as 
well as a checklist that providers 
can use when prescribing opioids 
for chronic pain. Checklist: 
http://stacks.cdc.gov/view/cdc/380
25 
This guideline is intended 
to improve 
communication between 
clinicians and patients 
about the risks and 
benefits of opioid therapy 
for chronic pain, improve 
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initiate or 
continue opioids for chronic pai
n; 2) opioid selection, dosage, 
duration, follow-up, and 
discontinuation; and 3) 
assessing risk and addressing 
harms of opioid use. 
 
and Evaluation 
(GRADE) 
framework, and 
recommendation
s were made on 
the basis of a 
systematic 
review of the 
scientific 
evidence. 
 the safety and 
effectiveness of pain 
treatment, and reduce the 
risks associated with 
long-term opioid therapy, 
including opioid use 
disorder, overdose, and 
death. 
 
Jamison, R. N., Scanlan, E., 
Matthews, M. L., Jurcik, D. C., 
& Ross E. L. (2016). 
Attitudes of primary care 
practitioners in managing 
chronic pain patients prescribed 
opioids for pain: A prospective 
longitudinal controlled trial. 
Purpose: To help determine 
whether patient risk assessment 
and incorporation of a 
structured opioid therapy 
protocol of monthly monitoring 
and compliance checklists 
would improve practitioner 
confidence in managing 
challenging chronic pain 
patients within a busy primary 
care center.  
 
Prospective 
longitudinal 
controlled 
trial (N=56 
PCPS, 
N=253 
patients) 
The following 
measures were 
administered to 
each of the 
primary care 
participants: 
background and 
prescribing 
practices 
questionnaire, 
general health 
questionnaire, 
opioid therapy 
survey, concerns 
about analgesic 
prescriptions, 
and test of opioid 
knowledge. 
The following 
measures were 
administered to 
each of the 
patients that 
After 1 year all the PCPs reported 
improvement in identifying 
patients at risk for misuse 
(P<0.05), perceived confidence in 
prescribing opioids for pain 
(P<0.05), and increased 
satisfaction with communication 
with pain specialists (P<0.05). The 
patients reported greater 
compliance with their opioid 
medication and felt that the 
monthly monitoring was 
beneficial. 
The results of this study 
demonstrated 
improvement in the 
number of practitioners 
who could identify 
patients at risk for misuse, 
were satisfied with 
communication are the 
center, and felt 
sufficiently trained in 
opioid prescribing. 
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participated: 
demographic 
questionnaire, 
the brief pain 
inventory, pain 
catastrophizing 
scale, the pain 
disability index, 
the hospital 
anxiety and 
depression scale, 
screener and 
opioid 
assessment for 
pain patients- 
revised, and the 
opioid 
compliance 
checklist. 
Zgierska, A. E., Vidaver, R. M., 
Smith, P., Ales, M. W., & 
Nisbet, K. (2018). 
Enhancing system-wide 
implementation of opioid 
prescribing guidelines in 
primary care: protocol for a 
stepped-wedge quality 
improvement project.  
Purpose: The goal of this 
quality improvement (QI) 
project is to assess whether a 
clinic-tailored QI intervention 
improves the implementation 
Multi-
pronged 
quality 
improveme
nt 
intervention 
A health system 
with 28 primary 
care clinics 
caring for 
approximately 
294,000 primary 
care patients 
developed and 
implemented a 
guideline driven 
policy on long-
term opioid 
therapy in adults 
with opioid 
The authors hypothesize that the 
addition of this intervention will 
enhance implementation of 
guideline-driven recommendations 
in primary care. 
Developing methods for a 
health system-tailored QI 
intervention required a 
multi-step process to 
incorporate end-user 
feedback and account for 
the needs of targeted 
clinic team members. 
Delivery of such tailored 
QI interventions can 
enhance uptake of opioid 
policies in primary care. 
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of a health system-wide, 
guideline-driven policy on 
opioid prescribing in primary 
care. 
treated chronic 
pain. The QI 
intervention 
included clinic-
wide and 
individual 
clinician-level 
educational 
interventions. To 
evaluate the 
impact of the QI 
intervention, the 
team collected 
two main types 
of date before, 
during, and after 
intervention: a) 
EHR-based 
clinic-level data 
on elements of 
the health 
system’s opioid 
policy; and b) 
process measures 
from the clinical 
staff, and project 
team 
experiences, and 
perceptions 
related to the QI 
intervention 
implementation. 
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Appendix E 
Donabedian Model 
 
 
 
 
Donabeidan, A. (1988). The quality of care: how can it be assessed? JAMA, 260, 1743-1748. 
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Appendix F 
 Plan Do Study Act Model 
 
 
 
 
Plan Do Study Act Model.  Langley, G. J., Moen, R. D., Nolan, K. M., Nolan, T. W., Norman, C. 
L., & Provost, L. P. (2009). The improvement guide: A practical approach to enhancing 
organizational performance, 2nd edition. San Francisco, CA: Jossey-Bass.  Used with permission 
from Wiley publishing. 
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Appendix G 
Health Care Organization Internal Review Board Determination Letter 
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Appendix H 
Grand Valley State University Internal Review Board Determination Letter 
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Appendix I 
Budget for Project 
Project Financial Operating Plan  
Standards of Care for Opioid Recipient Patients   
Revenue   
Project Manager Time (in-kind donation) 9,000.00 
Team Member Time:   
   Site Mentor Time (in-kind donation) 1,440.00 
   Primary Care Office Manager 450.00 
   6 Physicians (1 hour staff meeting) 600.00 
   1 Physician Assistant (1 hour staff meeting) 48.00 
   2 Registered Nurses (1 hour staff meeting) 52.00 
   2 Nurse Practitioners (1 hour staff meeting) 90.00 
Consultations:   
   Statistician 300.00 
    IT staff             160.00 
Cost of space            800.00 
TOTAL INCOME 12,940.00 
    
Expenses   
Project Manager Time (in-kind donation) 9,000.00 
Team Member Time:   
   Site Mentor Time (in-kind donation) 1,440.00 
   Primary Care Office Manager 450.00 
   6 Physicians (1 hour staff meeting) 600.00 
   1 Physician Assistant (1 hour staff meeting) 48.00 
   2 Registered Nurses (1 hour staff meeting) 52.00 
   2 Nurse Practitioners (1 hour staff meeting) 90.00 
Consultations:  
   Statistician 300.00 
   IT staff 160.00 
Laptop 800.00 
Cost of space 800.00 
Cost of printed education and toolkit material 40.00 
TOTAL EXPENSES 13,780.00 
  
OPERATING INCOME -840.00 
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Appendix J 
Approval of Use for Burke-Litwin Model 
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Appendix K 
Approval of Use for Donabedian Model 
*Awaiting 
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Appendix L 
Approval for Use of Plan Do Study Act Model 
 
 
